# Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Study · id `cardio:ct-nct04297592` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04297592](<https://clinicaltrials.gov/study/NCT04297592>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04297592

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 4618 participants.

## Technical summary

Registry record NCT04297592. Randomized; no masking; primary purpose prevention. Start 2020-06-11 (actual); primary completion 2027-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 4618 participants (planned count; ClinicalTrials.gov record NCT04297592, source copy `cardio:ctgov-nct04297592-2026-07-06`, retrieved 2026-10-26)
- Started: 2020-06-11 (actual) (ClinicalTrials.gov record NCT04297592, source copy `cardio:ctgov-nct04297592-2026-07-06`, retrieved 2026-10-26)
- Primary completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT04297592, source copy `cardio:ctgov-nct04297592-2026-07-06`, retrieved 2026-10-26)
- Completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT04297592, source copy `cardio:ctgov-nct04297592-2026-07-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04297592, source copy `cardio:ctgov-nct04297592-2026-07-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04297592-2026-07-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
- Condition: Infections Joint Prosthetic
- Condition: Overweight or Obesity
- Condition: MSSA Colonization
- Condition: MRSA
- Condition: Chronic Kidney Diseases
- Condition: Diabetes
- Condition: Autoimmune Diseases
- Condition: Inflammatory Disease
- Condition: Tobacco Use
- Intervention (Drug): Cephalexin
- Intervention (Drug): Doxycycline
- Intervention (Drug): Cefadroxil
- Lead sponsor: Mayo Clinic
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Mayo Clinic (`cardio:org-mayo-clinic`)

## Provenance

Content hash: 4f30871d6a7559910df29c2efe88516a7a59c94e730d2a316f444bfa653d800e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
